Literature DB >> 16574371

Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells.

Tae-Yong Shin1, Jay Min Oh, Byung-Ju Choi, Won-Hwan Park, Cheorl-Ho Kim, Chang-Duk Jun, Sang-Hyun Kim.   

Abstract

Mast cell-mediated allergic inflammation is involved in many diseases such as asthma, sinusitis, and rheumatoid arthritis. Mast cells induce synthesis and production of pro-inflammatory cytokines including tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 with immune regulatory properties. We investigated the effect of the fruits of Poncirus trifoliata (L.) Raf (Rutaceae) (FPT) on expression of pro-inflammatory cytokines by activated human mast cell line, HMC-1. FPT dose dependently decreased the gene expression and production of TNF-alpha and IL-6 on phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187-stimulated HMC-1 cells. In addition, FPT attenuated PMA and A23187-induced activation of NF-kappaB indicated by inhibition of degradation of I kappa B alpha, nuclear translocation of NF-kappaB, NF-kappaB/DNA binding, and NF-kappaB-dependent gene reporter assay. Our in vitro studies provide evidence that FPT might contribute to the treatment of mast cell-derived allergic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574371     DOI: 10.1016/j.tiv.2006.02.003

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  Antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus.

Authors:  Yoonki Heo; Yeondong Cho; Kwon Sung Ju; Hansam Cho; Ki Hoon Park; Hanul Choi; Jong Kwang Yoon; Chiung Moon; Young Bong Kim
Journal:  J Microbiol       Date:  2018-07-25       Impact factor: 3.422

2.  Expression of TNF-alpha and IL-6 in HMC-1 cells treated with bisphenol A is attenuated by plant-originating glycoprotein (75 kDa) by blocking p38 MAPK.

Authors:  Jin Lee; Kye-Taek Lim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-25       Impact factor: 3.000

3.  Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.

Authors:  Mark Borris Docdoc Aldonza; Ji-Young Hong; Song Yi Bae; Jayoung Song; Won Kyung Kim; Jedo Oh; Yoonho Shin; Seung Ho Lee; Sang Kook Lee
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

4.  Effects of Ethyl Acetate Extract of Poncirus trifoliata Fruit for Glucocorticoid-Induced Osteoporosis.

Authors:  Hyung-Young Yoon; Yun-Seok Cho; Qinglong Jin; Hyun-Gyu Kim; Eun-Rhan Woo; Yoon-Sok Chung
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

5.  Coumarins, furocoumarins and limonoids of Citrus trifoliata and their effects on human colon adenocarcinoma cell lines.

Authors:  Diána Kerekes; Attila Horváth; Norbert Kúsz; Botond Lajos Borcsa; Nikoletta Szemerédi; Gabriella Spengler; Dezső Csupor
Journal:  Heliyon       Date:  2022-08-29

6.  Ponciri Fructus Immaturus ethanol extract attenuates septic shock through inhibition of the STAT1 signaling pathway.

Authors:  Yo Sep Hwang; Jun-Pil Jang; Seong-Hoon Park; Aeyung Kim; Jae-Hyuk Jang; Hyang Ran Yoon; Suk Ran Yoon; Jun Hong Park; Hee Jun Cho; Hee Gu Lee
Journal:  Front Nutr       Date:  2022-09-15

7.  Poncirin Inhibits Osteoclast Differentiation and Bone Loss through Down-Regulation of NFATc1 In Vitro and In Vivo.

Authors:  Kwang-Hoon Chun; Hyun Chul Jin; Ki Sung Kang; Tong-Shin Chang; Gwi Seo Hwang
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634

Review 8.  The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators.

Authors:  Linh Pham; Leonardo Baiocchi; Lindsey Kennedy; Keisaku Sato; Vik Meadows; Fanyin Meng; Chiung-Kuei Huang; Debjyoti Kundu; Tianhao Zhou; Lixian Chen; Gianfranco Alpini; Heather Francis
Journal:  J Pineal Res       Date:  2020-11-29       Impact factor: 12.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.